The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- FUST Kabo secures accreditation for 20 courses, including medical programmes
- Masussuka: Amnesty International calls for transparent probe
- Utomi proposes N500/$ exchange rate, predicts 50% fall in food prices
- BUA Cement’s 9-month profit jumps 64% as revenue hits N1.09trn
- Dangote Refinery’s fuel exports surpass domestic supply at 54.63m litres daily
- Dangote Sugar returns to profitability with N78.17bn earnings
- Tinubu defends $21.7bn borrowing plan, says infrastructure critical to $1tn economy
- Sokoto, 29 other states endorse state police – Akpabio
